日本語のみで絞り込む

2022/4/8 -Interpretation: Combining androgen deprivation therapy, docetaxel, and abiraterone in de novo metastatic castration-sensitive prostate cancer ...

Karim Fizazi concluded his report of the PEACE-1 trial data by stating that the addition of abiraterone to ADT and docetaxel significantly improved radiographic ...

2022/4/21 -The investigators concluded: “Combining androgen deprivation therapy, docetaxel, and abiraterone in de novo metastatic castration-sensitive ...

2023/6/6 -ASCO 2023 results from the phase III PEACE-1 trial, prostate irradiation in men with de novo low-volume metastatic castrate-sensitive ...

A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer (PEACE1). The safety and scientific validity of this study is the responsibility ...

2018/12/6 -UNICANCER A Phase III of ADT + Docetaxel +/− Local RT +/− Abiraterone Acetate in Metastatic Hormone-Naïve Prostate Cancer (PEACE1) [ ...

2022/6/20 -In our exclusive interview, Dr Wise discussed practice-changing findings from the phase 3 ARASENS (NCT02799602) and PEACE1 (NCT01957436) trials.

2021/9/19 -ESMO21 PEACE1 trial. Docetaxel/Abiraterone/ADT vs Docetaxel/ADT in 1st line metastatic prostate cancer. Significant improvement in DFS and ...

2022/4/9 -Peace1 in @TheLancet —very important landmark study in metastatic castration-sensitive prostate cancer! #Triplets @OncoAlert.

(B) Sale Prohibited: 1. It shall be unlawful for any person to sell, offer for sale, exchange or barter, or give away any fireworks, firecrackers, Roman candles ...